Mcl-1 and Bcl-xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver

Hepatology

Volumn 50, Issue 4, 2009, Pages 1217-1226

  Hikita, Hayato ^a   Takehara, Tetsuo ^a   Shimizu, Satoshi ^a   Kodama, Takahiro ^a   Li, Wei ^a   Miyagi, Takuya ^a   Hosui, Atsushi ^a   Ishida, Hisashi ^a   Ohkawa, Kazuyoshi ^a   Kanto, Tatsuya ^a   Hiramatsu, Naoki ^a   Yin, Xiao Ming ^b   Hennighausen, Lothar ^c   Tatsumi, Tomohide ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CASPASE 7; FAS ANTIGEN; PROTEIN BCL XL; PROTEIN MCL 1; BCL2L1 PROTEIN, MOUSE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE PREDISPOSITION; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; HYPERAMMONEMIA; HYPERBILIRUBINEMIA; LIVER CELL; LIVER DEVELOPMENT; LIVER FAILURE; LIVER INJURY; LIVER METABOLISM; LIVER WEIGHT; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ALLELE; ANIMAL; BLOOD; GENETIC PREDISPOSITION; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ALANINE TRANSAMINASE; ALLELES; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 3; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTES; LIVER; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 70350070333     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23126     Document Type: Article

References (34)

1. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008;9:47-59.
2. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003;195:158-167.
3. Fischer U, Jänicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003;10:76-100.
4. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001;292:727-730.
5. Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, et al. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol 2006;44:151-157.
6. Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, Biesterfeld S, Müller M, et al. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int J Oncol 2006;28:25-32.
7. Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, et al. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer 2006;6:232.
8. Llovet JM, Bruix J. Molecular targeted therapies in hepatocellular carcinoma. HEPATOLOGY 2008;48:1312-1327.
9. Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006;66:11851-11858.
10. Casado M, Mollá B, Roy R, Fernández-Martínez A, Cucarella C, Mayoral R, et al. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. HEPATOLOGY 2007;45:631-638.
11. Schulze-Bergkamen H, Brenner D, Krueger A, Suess D, Fas SC, Frey CR, et al. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. HEPATOLOGY 2004;39:645-654.
12. Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, et al. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. HEPATOLOGY 2006;44:252-262.
13. Takehara T, Tatsumi T, Suzuki T, Rucker EB III, Hennighausen L, Jinushi M, et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 2004;127:1189-1197.
14. Dzhagalov I, St John A, He YW. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 2007;109:1620-1626.
15. Wagner KU, Claudio E, Rucker EB 3rd, Riedlinger G, Broussard C, Schwartzberg PL, et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development 2000;127:4949-4958.
16. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999;400:886-891.
17. Takehara T, Hayashi N, Tatsumi T, Kanto T, Mita E, Sasaki Y, et al. Interleukin 1β protects mice from Fas-mediated hepatocyte apoptosis and death. Gastroenterology 1999;117:661-668.
18. Takehara T, Takahashi H. Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. Cancer Res 2003;63:3054-3057.
19. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-1687.
20. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999;103:137-145.
21. Tosh D, Shen CN, Slack JM. Differentiated properties of hepatocytes induced from pancreatic cells. HEPATOLOGY 2002;36:534-543.
22. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993;75:229-240.
23. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci U S A 1994;91:3700-3704.
24. Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, et al. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A 1998;95:12424-12431.
25. Ross AJ, Waymire KG, Moss JE, Parlow AF, Skinner MK, Russell LD, et al. Testicular degeneration in Bclw-deficient mice. Nat Genet 1998;18:251-256.
26. Hamasaki A, Sendo F, Nakayama K, Ishida N, Negishi I, Nakayama K, et al. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 1998;188:1985-1992.
27. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995;267:1506-1510.
28. Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 2000;14:23-27.
29. Vick B, Weber A, Urbanik T, Maass T, Teufel A, Krammer PH, et al. Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. HEPATOLOGY 2009;49:627-636.
30. Yin XM. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 2006;369:7-19.
31. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008;134:1641-1654.
32. Kaestner KH. The making of the liver: developmental competence in foregut endoderm and induction of the hepatogenic program. Cell Cycle 2005;4:146-1148.
33. Cascio S, Zaret KS. Hepatocyte differentiation initiates during endodermal-mesenchymal interactions prior to liver formation. Development 1991;113:217-225.
34. Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H. Expression and role of Bcl-xL in human hepatocellular carcinomas. HEPATOLOGY 2001;34:55-61.